FOGHORN THERAPEUTICS INC (FHTX) Stock Analyst Ratings
USA - NASDAQ:FHTX - US3441741077 - Common Stock
4.21 USD
-0.2 (-4.54%)
4.21 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to FHTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.9. This target is 182.66% above the current price.
FHTX was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about FHTX.
In the previous month the buy percentage consensus was at a similar level.
FHTX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-30 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-23 | JMP Securities | Initiate | Market Outperform |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | B. Riley Securities | Initiate | Buy |
| 2024-12-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-16 | Jefferies | Maintains | Buy -> Buy |
| 2024-09-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-03 | Jefferies | Initiate | Buy |
| 2024-08-19 | Evercore ISI Group | Initiate | Outperform |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-06-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-09 | Wedbush | Maintains | Outperform |
| 2023-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2023-04-25 | BMO Capital | Maintains | Outperform |
| 2023-04-25 | Wedbush | Maintains | Outperform |
| 2023-03-28 | B of A Securities | Initiate | Buy |
| 2023-03-10 | Wedbush | Maintains | Outperform |
FOGHORN THERAPEUTICS INC / FHTX FAQ
What do analysts expect the price target to be for FOGHORN THERAPEUTICS INC (FHTX)?
13 analysts have analysed FHTX and the average price target is 11.9 USD. This implies a price increase of 182.66% is expected in the next year compared to the current price of 4.21.
What is the consensus rating for FHTX stock?
The consensus rating for FOGHORN THERAPEUTICS INC (FHTX) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.